首页> 外文学位 >ynfA, a novel Escherichia coli gene of the small multidrug resistance superfamily.
【24h】

ynfA, a novel Escherichia coli gene of the small multidrug resistance superfamily.

机译:ynfA,一种具有多重耐药小家族的新型大肠杆菌基因。

获取原文
获取原文并翻译 | 示例

摘要

ynfA, of Escherichia coli ( P76169 swissprot, g1787865 GenBank) is then newest Multidrug Resistance (SMR) gene family. It was identified with the aid of bioinformatics tools that allowed us to follow evolutionary principles of sequence conservation, in which functional similarity is inferred from sequence similarity, but surprisingly biochemical data yielded an unexpected mode of action for YnfA. The SMR gene family represents a prokaryotic transport system that is restricted to the eubacterial kingdom and has been so far identified in 63 bacterial species in both gram-negative and -positive bacterial species. Members of this family are composed of 100--120 amino acid residues in length and span the membrane four times as alpha-helices. A ynfA inframe deletion mutant was created from an isogenic wild type E. coli MG1655 that displayed no growth defect compared to its wild type isogenic pair. The ynfA deletion mutant appeared to have altered the partitioning of carbenicillin in such a way that it accumulated in the cytoplasm, thereby resulting in a carbenicillin resistant E. coli. Moreover the mutant resulted in an apparent alteration of the rate of uptake of carbenicillin into E. coli spheroplasts. A constructed multiple alignment revealed a highly conserved glutamic acid residue at position 14 among all of the members within the SMR superfamily. Predicted secondary structure and membrane topology localized the conserved glutamic acid residue to the first transmembrane alpha-helix. Upon mutation to alanine the substrate transport capability was abolished. The conserved glutamic acid residue at position 14 within the SMR family in E. coli corresponded to glutamic acid at position 15 in E. coli 's ynfA. ynfA's deletion or active site mutation of glutamic acid at position 15 to alanine-15 and expression in trans (by a plasmid) confers a gain of survival advantage, appearing as a recessive trait. Thereby, E. coli gains antibiotic resistance to penicillines and certain cephalosporins. Such a mechanism might play an important but currently unknown role in the rapid acquired resistance of human bacterial pathogens to many over-prescribed antibiotics. This is logically compelling since in this case, the gain in survivorship is not dependent on a horizontal transmission of genetic material, but on the loss of some internal genetic material.
机译:大肠杆菌的ynfA(P76169 swissprot,g1787865 GenBank)是最新的多重耐药(SMR)基因家族。借助于生物信息学工具进行了鉴定,该工具使我们能够遵循序列保守性的进化原理,其中从序列相似性推断出功能相似性,但是令人惊讶的是,生化数据为YnfA带来了意想不到的作用方式。 SMR基因家族代表了一个原核运输系统,该系统仅限于真细菌界,迄今为止已在革兰氏阴性菌和阳性菌种的63种细菌中鉴定出。该家族的成员由100--120个氨基酸残基组成,跨膜四倍于α螺旋。从同基因野生型大肠杆菌MG1655创建了一个ynfA读框缺失突变体,与其野生型同基因对相比,该菌株没有生长缺陷。 ynfA缺失突变体似乎已经改变了羧苄青霉素的分配,使其积累在细胞质中,从而产生了耐羧苄青霉素的大肠杆菌。此外,该突变体导致羧苄青霉素被大肠杆菌原生质球吸收的速率明显改变。构建的多重比对揭示了SMR超家族中所有成员中第14位的高度保守的谷氨酸残基。预测的二级结构和膜拓扑将保守的谷氨酸残基定位在第一个跨膜α-螺旋上。突变为丙氨酸后,底物转运能力被取消。大肠杆菌中SMR家族第14位的保守谷氨酸残基对应于大肠杆菌ynfA中第15位的谷氨酸。 ynfA的缺失或15位谷氨酸的活性位点突变为丙氨酸15并反式表达(通过质粒)赋予了生存优势,表现为隐性。因此,大肠杆菌对青霉素和某些头孢菌素具有抗生素抗性。这种机制可能在人类细菌病原体对许多过量处方抗生素的快速获得性耐药中起重要但目前未知的作用。从逻辑上讲,这是令人信服的,因为在这种情况下,生存率的提高不取决于遗传物质的水平传播,而是取决于某些内部遗传物质的损失。

著录项

  • 作者

    Hus, Nir.;

  • 作者单位

    University of Miami.;

  • 授予单位 University of Miami.;
  • 学科 Biology Molecular.; Biology Microbiology.
  • 学位 Ph.D.
  • 年度 2005
  • 页码 122 p.
  • 总页数 122
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子遗传学;微生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号